CALECIM® Strengthens Professional Community team with Former L’Oreal and OLAPLEX Executives:

• Senior executives Gil Dalva and Tyler Krebs, both ex-OLAPLEX executives, join CALECIM® to fortify the brand’s penetration into the hair professionals' domain.

• Alfredo Lewis, ex-L’Oréal Chief Engagement Officer, and renowned stylist influencer, also joins the CALECIM® team as an educator, advisor, and Key Opinion Leader (KOL).

10th January 2024, Singapore: To reinforce its professional community development, CellResearch Consumer Health has secured the expertise of ex-OLAPLEX executives, Tyler Krebs and Gil Dalva. These industry veterans, who previously held influential roles as Chief Marketing Officer and Head of International Business at OLAPLEX respectively, are poised to utilize their extensive beauty industry experience to position CALECIM® as the leading professional solution for enhancing hair health and reversing hair thinning.

The addition of these OLAPLEX veterans significantly boosts CALECIM®’s proficiency in the salon sector. Under their leadership, OLAPLEX witnessed exponential growth in the professional channel and was acquired by Advent in 2019. While the terms of the deal remain undisclosed, industry insiders estimate OLAPLEX’s valuation at around $1 billion, post a sales revenue of over $100 million.

CALECIM® is part of CellResearch Consumer Health’s brand portfolio, offering revolutionary skincare products designed to combat aging and hair thinning. With an expansive network of over a million hairstylists and beauty professionals operating in approximately 86,000 salons across the USA, the brand’s growth potential within the hair professional space is substantial.

Tyler Krebs, ex-Chief Marketing Officer and Chief Technology Officer at OLAPLEX, expressed his enthusiasm about the transition, stating, "Joining CALECIM® provides an exciting platform to contribute to the evolution of stem cell-derived skincare and haircare solutions. The brand’s innovative approach and commitment to excellence align seamlessly with our vision for shaping the future of professional beauty."

Gil Dalva, formerly the Head of International Business for OLAPLEX and RevitaLash, added, "I am thrilled to join the CALECIM® team, working towards establishing it as a leader in improving scalp and hair health. The potential for innovation in stem cell-derived products is immense, and I am eager to drive growth and excellence within the professional community."

In addition to the OLAPLEX duo, CALECIM® has also welcomed Alfredo Lewis, an ex-L'Oréal Chief Engagement Officer and influential stylist, as an educator, advisor, and Key Opinion Leader (KOL). Lewis shared his perspective on the venture, stating, "Being a part of CALECIM® enables me to leverage my insights and experience towards a brand that is revolutionizing the professional beauty industry. I am excited to shape the future of haircare solutions."

The U.S. beauty and personal care sector generates over $80 billion in annual revenue, according to industry reports. Globally, there are approximately 1.5 million salons and over 20 million beauty and skincare professionals. With such a vast and dynamic landscape, CALECIM®'s market entry presents a significant opportunity to make a substantial impact.

The brand's innovative stem cell-derived solutions cater to the growing demand for cutting-edge products, providing professionals with a unique offering to elevate their services and

meet the evolving consumer preferences. As the industry continues to expand, CALECIM®'s disruptive approach positions it as a key player in shaping the future of professional beauty, capturing the attention and loyalty of stylists and salons across the United States and beyond.

Gavin Tan, CEO of CellResearch, highlighted the significance of these appointments, stating, "We are thrilled to have industry veterans like Tyler, Gil, and Alfredo on board with CALECIM®. Their wealth of experience and expertise will be instrumental in propelling our vision forward. We are committed to becoming the leading professional solution for improving hair and scalp health, and their contributions will be invaluable in achieving this goal."

About CellResearch Corporation (“CRC”)

Founded in 2002, CellResearch Corporation initially served as a contract research provider focusing on skin cells. In 2004, the company discovered that the umbilical cord lining of mammals was a rich source of both mesenchymal and epithelial stem cells. Currently, the company owns this technology through a family of patents and holds the rights to commercialize this technology in most major markets globally. CellResearchCorp has a broad therapeutic pipeline at the pre-clinical stage.

CellResearch Consumer Health Pte Ltd, a wholly owned subsidiary of CellResearchCorp, produces an innovative range of skincare and hair care products powered by cord lining stem cell media. It is home to two innovative brands, Calecim® Professional: Anti-aging skincare and haircare brand and Sollagen™: Diabetic Skincare, both powered by a proprietary ingredient: PTT-6™, a complex mixture of peptides and growth factors derived from cord lining stem cells.

About CALECIM®

CALECIM® is a brand under CellResearch Consumer Health’s portfolio. It offers revolutionary skincare products designed to combat aging and hair thinning. CALECIM® is powered by a patented active ingredient: PTT-6™, a mixture of over 3000 proteins and growth factors that significantly improve skin and hair health.

www.cellresearchcorp.com

https://calecimprofessional.com

Xavier Simpson

T:+65 8815 6139

E: xaviersimpson@cellresearchcorp.com